|
|
||||||||
Clinical Chemistry, Vol 11, 645-652, Copyright © 1965 by the American Association for Clinical Chemistry
1 Department of Pathology, Hartford Hospital.
2 Research Laboratories, Department of Medicine, Hartford Hospital, Hartford, Conn. 06115.
A method has been developed for demonstrating atypical serum cholinesterase by means of the self-indicating substrate, o-nitrophenylbutyrate and the inhibitor succinyldicholine. The procedure was tested for atypical cholinesterase with 76 individuals, including 5 otherwise proven homozygotes and their immediate families. In all cases, it was possible to distinguish clearly those individuals homozygous for the usual and atypical cholinesterase as well as heterozygotes.
Submitted on December 15, 1964
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |